Transcatheter Embolization And Occlusion Devices Market to Grow with a CAGR of 6.80% through 2029

Shift towards minimally invasive procedures and growing awareness among healthcare providers is expected to drive the Global Transcatheter Embolization And Occlusion Devices Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “Transcatheter Embolization And Occlusion Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Transcatheter Embolization And Occlusion Devices Market stood at USD 2.52 billion in 2023 and is anticipated to grow with a CAGR of 6.80% in the forecast period, 2025-2029. This can be attributed to evolving healthcare infrastructure. The Transcatheter Embolization and Occlusion Devices Market is experiencing significant growth driven by advancements in healthcare technology and rising demand for minimally invasive treatment options. These devices play a crucial role in the management of various medical conditions, including vascular malformations, tumors, and hemorrhages, by blocking or reducing blood flow to targeted areas. As healthcare infrastructure continues to improve globally, particularly in emerging economies, there is a growing adoption of transcatheter procedures due to their effectiveness and reduced patient recovery times. Moreover, the integration of artificial intelligence (AI) into healthcare is revolutionizing procedural planning and patient selection, enhancing the accuracy and efficacy of transcatheter embolization and occlusion procedures. Additionally, ongoing research and development efforts are focused on designing next-generation devices with improved safety profiles, better navigational capabilities, and enhanced compatibility with imaging modalities. With a rising prevalence of cardiovascular diseases and an aging population worldwide, the demand for transcatheter embolization and occlusion devices is expected to further increase, driving market expansion and innovation in the years to come.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Transcatheter Embolization And Occlusion Devices Market”

Embolization offers a less invasive alternative to open surgery and stands as a highly effective method for managing bleeding. These devices effectively circumvent complications such as inaccurate deployment, catheter entrapment, and balloon deflation, commonly associated with coiling. Consequently, there is a growing trend among surgeons to opt for non-coil devices to harness their associated benefits, which is expected to stimulate the demand for Transcatheter Embolization (TEO) devices.

According to the National Institute of Health (NIH), lung cancer is the most frequently diagnosed type globally, with over 1,350,000 cases detected each year. Additionally, a report from the Cleveland Clinic highlights that approximately 76,000 individuals in the United States receive diagnoses of malignant kidney tumors. Furthermore, the National Library of Medicine (NLM) reports that over 250 million people are living with unruptured aneurysms. Transcatheter embolization devices play a crucial role in curtailing blood flow in these cases, preventing them from rupturing.

As per a report from Yale Medicine, more than 70 million individuals are afflicted by vascular malformations, and transcatheter embolization devices are employed to control blood flow while minimizing blood loss. Government initiatives aimed at enhancing healthcare infrastructure and increased healthcare expenditures are propelling the market's growth. In 2021, the United States allocated USD 4.3 trillion to healthcare spending, while China's healthcare expenditure reached USD 1.1 trillion.

The Global Transcatheter Embolization And Occlusion Devices Market is segmented into product, application, regional distribution, and company.

Based on product, the non-coil category emerged as the primary source of revenue in 2023. This is ascribed due to their versatility and applicability to a wide range of clinical scenarios. Unlike coils, non-coil devices encompass a diverse array of options such as liquid embolics, microspheres, plugs, and balloons, each tailored to specific treatment needs. This variety allows healthcare providers to select the most appropriate device based on factors like vessel size, lesion characteristics, and procedural objectives. Non-coil devices often offer enhanced navigational capabilities and precision, facilitating more targeted embolization and occlusion procedures. The development of advanced materials and delivery systems has led to improved safety profiles and procedural outcomes for non-coil devices. The non-coil devices are increasingly favored for their ability to achieve complete and durable occlusion of target vessels, reducing the risk of recurrence and the need for repeat procedures. As a result of these advantages, non-coil devices have become the preferred choice for transcatheter embolization and occlusion procedures, driving their dominance in the market.

Based on application, the neurology sector is anticipated to grow because of the rising incidence of severe neurological disorders worldwide, such as brain aneurysms and cerebral arteriovenous malformations. According to data from the Society of NeuroInterventional Surgery, the market currently offers more than 140 Guglielmi detachable coils in various sizes, which have been employed in the treatment of over 125,000 patients worldwide. Consequently, the brain aneurysm market is poised for significant expansion during the projected period.

Major companies operating in Global Transcatheter Embolization And Occlusion Devices Market are:

·         Boston Scientific Corp

·         Terumo Corp

·         Medtronic PLC

·         DePuy Synthes Inc

·         Stryker Corp

·         Cordis Corp

·         Abbott Laboratories Inc

·         Pfizer Inc

·         Sirtex Medical Inc

·         Nordion Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The global market for transcatheter embolization and occlusion devices is undergoing notable evolution, driven by key trends that will shape its future trajectory. As these devices find expanded applications and technology advances, coupled with the rising prominence of personalized medicine, market growth is anticipated to persist. The convergence of these trends promises to make transcatheter embolization and occlusion procedures more efficient, effective, and widely available, ultimately enhancing patient outcomes and advancing healthcare as a whole” said Mr. Karan Chechi, Research Director, TechSci Research, a research-based management consulting firm.

“Transcatheter Embolization And Occlusion Devices Market By Product (Coil (Pushable Coils, Detachable Coils), Non-Coil (Flow Diverting Devices, Embolization Particles, Liquid Embolics, Other Embolization and Occlusion Devices, Accessories)), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Others), By Region, By Competition Forecast & Opportunities, 2019-2029F”, has evaluated the future growth potential of Global Transcatheter Embolization And Occlusion Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Transcatheter Embolization And Occlusion Devices Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com